Amanote Research
Register
Sign In
Single-Agent Thalidomide for Treatment of First Relapse Following High-Dose Chemotherapy in Patients With Multiple Myeloma
Leukemia
- United Kingdom
doi 10.1038/sj.leu.2403564
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Date
October 28, 2004
Authors
R Fenk
B Hoyer
U Steidl
M Kondakci
T Graef
R Heuk
L Ruf
C Strupp
F Neumann
U-P Rohr
B Hildebrandt
R Haas
G Kobbe
Publisher
Springer Nature
Related search
Successful Treatment of Extramedullary Tumors With Low-Dose Thalidomide in Patients With Multiple Myeloma
Internal Medicine
Internal Medicine
Medicine
Efficacy of Single-Agent Bortezomib vs. Single-Agent Thalidomide in Patients With Relapsed or Refractory Multiple Myeloma: A Systematic Comparison
European Journal of Haematology
Medicine
Hematology
Infectious Complications in Patients With Multiple Myeloma on First Chemotherapy Cycle
Oncogematologiya
Oncology
Hematology
Phase II Study of Bendamustine, Bortezomib and Dexamethasone (BBD) in the First-Line Treatment of Patients With Multiple Myeloma Who Are Not Candidates for High Dose Chemotherapy
British Journal of Haematology
Hematology
Maintenance Therapy With Low Dose Thalidomide, Dexamethasone and Clarithromycin (BLT-D) Following Autologous Transplant (ASCT) for Multiple Myeloma (MM)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Effect of Thalidomide on Stem Cell Collection and Engraftment in Patients With Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Infectious Complications After High-Dose Chemotherapy and Autologous Stem Cell Transplantation: Comparison Between Patients With Lymphoma or Multiple Myeloma and Patients With Solid Tumors
Bone Marrow Transplantation
Transplantation
Hematology